Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol

This article has no abstract
Epistemonikos ID: 1483e2cda06dc2e1da081ba7aed93ccb77cca821
First added on: Feb 07, 2025